Stock 177A KOHJIN BIO CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Kohjin Bio Co., Ltd.

Equities

177A

JP3283630006

Pharmaceuticals

Delayed Japan Exchange
Other stock markets
 01:59:28 2024-06-18 am EDT 		5-day change 1st Jan Change
1,699 JPY -2.91% Intraday chart for Kohjin Bio Co., Ltd. +1.13% 0.00%
Apr. 25 Kohjin Bio Co., Ltd. has completed an IPO in the amount of ¥1.615 billion. CI

Valuation

Fiscal Period: März 2025 2026
Capitalization 1 8,776 -
Enterprise Value (EV) 1 8,776 8,776
P/E ratio 14.1 x 13.1 x
Yield 0.8% 0.8%
Capitalization / Revenue 1.86 x 1.71 x
EV / Revenue 1.86 x 1.71 x
EV / EBITDA 7.39 x 6.19 x
EV / FCF -34.6 x -46.4 x
FCF Yield -2.89% -2.15%
Price to Book 1.66 x 1.49 x
Nbr of stocks (in thousands) 5,015 -
Reference price 2 1,750 1,750
Announcement Date - -
1JPY in Million2JPY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: März 2024 2025 2026
Net sales 1 4,770 4,717 5,130
EBITDA 1 - 1,188 1,418
EBIT 1 596 799 891
Operating Margin 12.49% 16.94% 17.37%
Earnings before Tax (EBT) 1 635 830 907
Net income 1 384 618 671
Net margin 8.05% 13.1% 13.08%
EPS 2 92.43 124.5 133.7
Free Cash Flow 1 - -254 -189
FCF margin - -5.38% -3.68%
FCF Conversion (EBITDA) - - -
FCF Conversion (Net income) - - -
Dividend per Share 2 14.00 14.00 14.00
Announcement Date 5/15/24 - -
1JPY in Million2JPY
Estimates

Balance Sheet Analysis

Fiscal Period: März 2024 2025 2026
Net Debt - - -
Net Cash position - - -
Leverage (Debt/EBITDA) - - -
Free Cash Flow 1 - -254 -189
ROE (net income / shareholders' equity) 12.1% 14.5% 12%
ROA (Net income/ Total Assets) - - -
Assets 1 - - -
Book Value Per Share 2 803.0 1,056 1,176
Cash Flow per Share 164.0 - -
Capex 1 - 186 1,167
Capex / Sales - 3.94% 22.75%
Announcement Date 5/15/24 - -
1JPY in Million2JPY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
KOHJIN BIO CO., LTD. Stock Kohjin Bio Co., Ltd.
0.00% 55.61M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+51.82% 797B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+40.45% 628B
MERCK & CO., INC. Stock Merck & Co., Inc.
+16.95% 323B
ABBVIE INC. Stock AbbVie Inc.
+9.49% 300B
ASTRAZENECA PLC Stock AstraZeneca PLC
+17.25% 244B
ROCHE HOLDING AG Stock Roche Holding AG
+0.41% 223B
NOVARTIS AG Stock Novartis AG
+10.22% 214B
AMGEN INC. Stock Amgen Inc.
+5.30% 163B
PFIZER, INC. Stock Pfizer, Inc.
-6.29% 153B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 177A Stock
  4. Financials Kohjin Bio Co., Ltd.